DWTX
Dogwood Therapeutics, Inc.
$1.49
-0.01 (-0.67%)
At close · Jul 2
Market Cap
$50.11M
Shares
33,629,553
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.49
Open$1.54
Day$1.45–1.61
52W$1.28–9.50
Avg vol 30d81K
Short int27K · 0.1% float · 1.0d
Short vol14%
Last earningsMay 14, 2026
DataDec 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−59% below
−
Price vs 50-day avg
−6% below
◦
RSI (14)
44 · neutral
+
MACD trend
positive
−
52-week position
3% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $2 › 200d $4 — 200d above 50d
+
Institutional flow
+30% holders QoQ · +6 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.08% of float · ▼ -58.6% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
13 holders — mid 1-yr range
Fundamentals
Excellent
+
EPS growth
+43% Y/Y
+
Valuation
P/E 1.3 · below peers
+
Balance sheet
net cash $6.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−59% below
Bearish
Price vs 50-day avg
−6% below
Bearish
RSI (14)
44 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+30% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -58.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 3%
52-wk high $10
vs 200-day avg -59%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DWTX
this stock
Dogwood Therapeutics, Inc.
|
$50.11M | -64.2% | — | 1.3 | 0.1% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DWTX | +0.7% | -7.5% | -52.7% | -7.5% | -64.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -0.8% | -6.2% | -60.7% | -7.2% | -73.4% |